loader image
Saturday, December 13, 2025
68.5 F
McAllen
- Advertisement -

Does Depression and Anxiety Increase Cancer Risk?

Translate to Spanish or other 102 languages!

The global prevalence of depression and anxiety continues to increase. Image for illustration purposes
The global prevalence of depression and anxiety continues to increase. Image for illustration purposes

Medical News Today

- Advertisement -
  • About 5% of the world’s adult population has depression, and about 40-50% of those with major depression will also experience anxiety. 
  • Previous studies have linked depression and anxiety to an increased risk for certain diseases, including cancer. 
  • Researchers from the University Medical Center Groningen have discovered evidence to challenge the theory that depression and anxiety increase a person’s cancer risk.

Depression affects about 5% of the world’s adult populationTrusted Source. People with depression often have additional mental health issues, most notably anxiety

Follow the link below to read the full article on Medical News Today:

https://www.medicalnewstoday.com/articles/does-depression-and-anxiety-increase-cancer-risk?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-08-15&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Tips to Tame the ‘Sunday Scaries’

Weekends only last so long, and if you start feeling anxious by Sunday, you're not alone.

Watercress A Nutrient-Dense Leafy Green

Watercress is a leafy green that naturally grows in clean, slow-moving water and belongs to the same plant family as mustard greens, kale, and cabbage. It has a mild, peppery taste and can be eaten raw or cooked in many different meals.

Off-the-Shelf Immunotherapy Offers Hope for Aggressive Myeloma

A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can generate deep and durable responses in extramedullary multiple myeloma — one of the most aggressive and treatment-resistant forms of the disease. 

FDA Approves Zenflow Spring® System for BPH Treatment

 Zenflow, Inc. announced today the U.S. Food and Drug Administration (FDA) approval of the Zenflow Spring® Implant and Delivery System for the treatment of symptoms associated with benign prostatic hyperplasia (BPH), also known as enlarged prostate.
- Advertisement -
×